Clinical Data from First Subject Dosed Twice Daily with QRX003 in Open Label Study Is Positive at Mid-point of ...

The study is one of five clinical efforts - three proof-of-concept investigator-initiated trials (IIT) and two Phase 2 studies - of crofelemer ...

Huntsman Cancer Institute at the University of Utah (the U) has joined other institutions in an innovative clinical trials ...

Regulatory Approval Showcases Clinical Advancement of Linea DNA™ as a Rapid and Effective Means of Producing CAR-T cell ...

Improvements Across Measures of Behavior, Function, Cognition and Movement -- Expediting Plans to Advance CT1812 into Late-Stage Trials -- Full ...

The study results support prior epidemiological research suggesting cardiovascular benefits with moderate wine drinking.

PLC (NASDAQ:TCBP) announced that its Board of Directors approved a special dividend of 0.25 American Depositary Shares for ...

Vitamin D and calcium are essential for overall health but don't reduce the risk of falls or fractures in generally healthy ...

A multicenter randomized, controlled clinical trial aims to test whether a minimally invasive treatment can relieve chronic ...

Clinical Data from First Subject Dosed Twice Daily with QRX003 in Open Label Study Is Positive at Mid-point of TestingSignificant Improvement in Skin Appearance Observed in Pediatric Study after Only ...

Additionally, results from preclinical studies provide proof-of-mechanism for recovery of muscle function with ClC-1 inhibition using NMD670 in CMT mouse models Aarhus, Denmark, 18 December 2024 – NMD ...

Race Oncology appoints experienced biotech executive Dr Megan Baldwin as a non-executive director. ... Read More The post ...